SCROLL
TOP
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
R&D
Immunology Research Institute
Inflammatory autoimmune diseases are caused by disruption of immune homeostasis, which is finely controlled by immune cell responses.
Central Research Institute
Central Research Institute (CRI) aims to develop promising peptide drugs for treating neuroinflammatory diseases with special focus on Alzheimer’s disease, the leading cause of dementia in old age.
Immunology Research Institute
Inflammatory autoimmune diseases are caused
by disruption of immune homeostasis,
which is finely controlled
by immune cell responses.
Central Research Institute
Central Research Institute (CRI) aims to develop
promising peptide drugs for treating
neuroinflammatory diseases with special focus on
Alzheimer’s disease, the leading cause
of dementia in old age.
PIPELINE
PIPELINE
Detail
Autoimmune
Rheumatoid Arthritis (RA)
KINE-101A
Inflammatory Bowel Disease (IBD)
KINE-101B
PNS
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
KINE-101C
Metabolite
Non-Alcoholic Steatohepatitis (NASH)
KINE-101D
Dermatology
Atopic dermatitis
KINE-201A
Respiratory
Asthma
KINE-201B
Chronic Obstructive Pulmonary Disease (COPD)
KINE-201C
Dermatology
Psoriasis
KINE-301A
Cancer
Solid tumor
KINE-401A
CNS
Alzheimer's disease
KINE-501A
Frontotemporal Dementia (FTD)
KINE-501B
Lewy Body Dementia (LBD)
KINE-501C
Parkinson's disease
KINE-501D
Other
Wound healing
KINE-601A
Alopecia
KINE-601B
Autoimmune
Rheumatoid Arthritis (RA)
KINE-101A
Inflammatory Bowel Disease (IBD)
KINE-101B
PNS
Chronic Inflammatory Demyelinating
Polyradiculoneuropathy (CIDP)
KINE-101C
Metabolite
Non-Alcoholic Steatohepatitis (NASH)
KINE-101D
Dermatology
Atopic dermatitis
KINE-201A
Respiratory
Asthma
KINE-201B
Chronic Obstructive Pulmonary Disease (COPD)
KINE-201C
Dermatology
Psoriasis
KINE-301A
Cancer
Solid tumor
KINE-401A
CNS
Alzheimer's disease
KINE-501A
Frontotemporal Dementia (FTD)
KINE-501B
Lewy Body Dementia (LBD)
KINE-501C
Parkinson's disease
KINE-501D
Other
Wound healing
KINE-601A
Alopecia
KINE-601B
News & Notice
News and information
from Kine Sciences
NEWS
[중앙일보][헬스&바이오] 희귀질환 CIDP 근본적 치료제에 도전 … 내년 상반기‘KINE-101’임상 2상 시작
2023.12.28
more view
NEWS
[더벨][VC 투자기업]카인사이언스 핵심 파이프라인, 임상 2상 진입한다
2023.12.28
more view
NOTICE
제8기 정기주주총회 관련 주주명부 기준일 명의개서정지 공고
2023.12.15
more view
NOTICE
임시주주총회 소집공고
2023.06.15
more view
NOTICE
임시주주총회 관련 주주명부 기준일 명의개서정지 공고
2023.06.07
more view
NOTICE
제7기 결산공고
2023.03.29
more view
CAREER
Join with Kine Sciences
now to make new future